The current study revealed that GSTZ1‐1 expression is markedly downregulated in HCC, which contributed to tumor progression and poor prognosis, providing evidence supporting recent reports that GSTZ1‐1 is decreased in HCC (Jahn et al, 2016; Nwosu et al, 2017). This evidence concerns the gene GSTZ1 and neoplasm.